Specialty
Aesthetics Cataract & Refractive Dermatology General Ophthalmology Glaucoma Interventional Radiology Neurology Optometry Retina Women's Health View All Courses
Course Type
Supplement Multimedia Webinar In-Person Multi-Part Collection
Search
Log In

Case Studies in Dry Eye Management: Appropriate Treatment-Decisions for Your Patients

By: Preeya K. Gupta, MD; Joseph Tauber, MD

Webinar Credits: 1

Expiration Date: Tuesday, December 31, 2019
Release Date: December 2018

EXPIRATION Dates:
AMA PRA Category 1 Credit Expiration date: December 31, 2019
COPE Expiration date: December 5, 2021

Learning Objectives

Upon completion of this activity, the participant should be able to:
Discuss the prevalence of dry eye disease and the related signs and symptoms of patients.
Develop a differential diagnosis for patients with complaints of dry eye.
Propose an individualized treatment plan for patients using current U.S. Food and Drug Administration-approved therapies.
Evaluate how dry eye disease can complicate surgical outcomes and how best to manage dry eye disease in these states.
Differentiate the need for constant maintenance and ongoing ophthalmic care for the various dry eye disease treatments.

Accreditation and Designation Statement

Accreditation Statement
Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement
Evolve designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In cooperation with Evolve Medical Education LLC, the University of Houston College of Optometry has reviewed and endorsed this course.

Evolve is an approved COPE Administrator. This course is COPE approved for 1.0 hours of CE Credit for Optometrists.
COPE Course ID: 60144-AS
COPE Event ID: 116613

COPE Expiration date: December 5, 2021

Faculty and Disclosures

Preeya K. Gupta, MD,
has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon/Novartis; Allergan/Actavis; Aurea; Biotissue; Carl Zeiss Meditec; Johnson & Johnson Vision; Novabay Pharmaceuticals; Ocular Science; Shire; TearLab; and TearScience.

Joseph Tauber, MD,
has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant and Speaker’s Bureau: Shire.

Editorial Support Disclosure
Michelle Dalton, Writer, Susan Gallagher-Pecha, director of client services and project management, Evolve Medical Education LLC, and Erin Fletcher, MIT, Evolve Medical Education LLC, have no real or apparent conflicts of interest to report. Jaya Kumar, MD, peer reviewer has no conflict of interest to report.

 

Disclaimer

Off-Label Statement
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, or Shire.

Policy on Privacy and Confidentiality

OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications,
and warnings.

DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Shire.

Pretest

Video Resources

Next

Test

Instructions

Step 1 of 3

33%
  • AgreeNeutralDisagree
    Discuss the prevalence of dry eye disease and the related signs and symptoms of patients.
    Develop a differential diagnosis for patients with complaints of dry eye.
    Propose an individualized treatment plan for patients using current U.S. Food and Drug Administration-approved therapies.
    Evaluate how dry eye disease can complicate surgical outcomes and how best to manage dry eye disease in these states.
    Differentiate the need for constant maintenance and ongoing ophthalmic care for the various dry eye disease treatments.
Back